Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nucleic Acid-based Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nucleic Acid-based Therapeuticsmarket, defines the market attractiveness level of Nucleic Acid-based Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nucleic Acid-based Therapeutics industry, describes the types of Nucleic Acid-based Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nucleic Acid-based Therapeutics market and the development prospects and opportunities of Nucleic Acid-based Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nucleic Acid-based Therapeutics market in Chapter 13.
By Player:
Protagonist Therapeutics
Benitec Biopharma
EGEN
Transgene
Caperna
Copernicus Therapeutics
Wave Life Sciences
Phylogica
BioMedica
Imugene
By Type:
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
By End-User:
Monogenetic Disorders
Multi-Genetic Disorders
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nucleic Acid-based Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nucleic Acid-based Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nucleic Acid-based Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nucleic Acid-based Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nucleic Acid-based Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.2 United States Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.3 Europe Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.4 China Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.5 Japan Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.6 India Nucleic Acid-based Therapeutics Consumption (2017-2022)
-
7.7 South Korea Nucleic Acid-based Therapeutics Consumption (2017-2022)
8 Region and Country-wise Nucleic Acid-based Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Nucleic Acid-based Therapeutics Consumption Forecast (2022-2028)
9 Global Nucleic Acid-based Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Nucleic Acid-based Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-Sense And Anti-Gene Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Short Inhibitory Sequences Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Gene Transfer Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nucleoside Analogs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Ribozymes Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Aptamers Consumption and Growth Rate (2017-2022)
-
9.2 Global Nucleic Acid-based Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Monogenetic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Multi-Genetic Disorders Consumption and Growth Rate (2017-2022)
10 Global Nucleic Acid-based Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-Sense And Anti-Gene Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Short Inhibitory Sequences Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Gene Transfer Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Nucleoside Analogs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Ribozymes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Monogenetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Multi-Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
11 Global Nucleic Acid-based Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nucleic Acid-based Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nucleic Acid-based Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nucleic Acid-based Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nucleic Acid-based Therapeutics Market Competitive Analysis
-
14.1 Protagonist Therapeutics
-
14.1.1 Protagonist Therapeutics Company Details
-
14.1.2 Protagonist Therapeutics Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Product and Service
-
14.2 Benitec Biopharma
-
14.2.1 Benitec Biopharma Company Details
-
14.2.2 Benitec Biopharma Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Benitec Biopharma Nucleic Acid-based Therapeutics Product and Service
-
14.3 EGEN
-
14.3.1 EGEN Company Details
-
14.3.2 EGEN Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 EGEN Nucleic Acid-based Therapeutics Product and Service
-
14.4 Transgene
-
14.4.1 Transgene Company Details
-
14.4.2 Transgene Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Transgene Nucleic Acid-based Therapeutics Product and Service
-
14.5 Caperna
-
14.5.1 Caperna Company Details
-
14.5.2 Caperna Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Caperna Nucleic Acid-based Therapeutics Product and Service
-
14.6 Copernicus Therapeutics
-
14.6.1 Copernicus Therapeutics Company Details
-
14.6.2 Copernicus Therapeutics Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Product and Service
-
14.7 Wave Life Sciences
-
14.7.1 Wave Life Sciences Company Details
-
14.7.2 Wave Life Sciences Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Wave Life Sciences Nucleic Acid-based Therapeutics Product and Service
-
14.8 Phylogica
-
14.8.1 Phylogica Company Details
-
14.8.2 Phylogica Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Phylogica Nucleic Acid-based Therapeutics Product and Service
-
14.9 BioMedica
-
14.9.1 BioMedica Company Details
-
14.9.2 BioMedica Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 BioMedica Nucleic Acid-based Therapeutics Product and Service
-
14.10 Imugene
-
14.10.1 Imugene Company Details
-
14.10.2 Imugene Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Imugene Nucleic Acid-based Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nucleic Acid-based Therapeutics
-
Figure Nucleic Acid-based Therapeutics Picture
-
Table Global Nucleic Acid-based Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nucleic Acid-based Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nucleic Acid-based Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nucleic Acid-based Therapeutics Consumption by Country (2017-2022)
-
Figure United States Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nucleic Acid-based Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleic Acid-based Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nucleic Acid-based Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-Sense And Anti-Gene Consumption and Growth Rate (2017-2022)
-
Figure Global Short Inhibitory Sequences Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Transfer Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleoside Analogs Consumption and Growth Rate (2017-2022)
-
Figure Global Ribozymes Consumption and Growth Rate (2017-2022)
-
Figure Global Aptamers Consumption and Growth Rate (2017-2022)
-
Figure Global Monogenetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Multi-Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Sense And Anti-Gene Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short Inhibitory Sequences Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gene Transfer Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleoside Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ribozymes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aptamers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monogenetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multi-Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nucleic Acid-based Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nucleic Acid-based Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Protagonist Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Protagonist Therapeutics Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protagonist Therapeutics Nucleic Acid-based Therapeutics Product and Service
-
Table Benitec Biopharma (Foundation Year, Company Profile and etc.)
-
Table Benitec Biopharma Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Benitec Biopharma Nucleic Acid-based Therapeutics Product and Service
-
Table EGEN (Foundation Year, Company Profile and etc.)
-
Table EGEN Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table EGEN Nucleic Acid-based Therapeutics Product and Service
-
Table Transgene (Foundation Year, Company Profile and etc.)
-
Table Transgene Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Transgene Nucleic Acid-based Therapeutics Product and Service
-
Table Caperna (Foundation Year, Company Profile and etc.)
-
Table Caperna Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Caperna Nucleic Acid-based Therapeutics Product and Service
-
Table Copernicus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Copernicus Therapeutics Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Copernicus Therapeutics Nucleic Acid-based Therapeutics Product and Service
-
Table Wave Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Wave Life Sciences Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wave Life Sciences Nucleic Acid-based Therapeutics Product and Service
-
Table Phylogica (Foundation Year, Company Profile and etc.)
-
Table Phylogica Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Phylogica Nucleic Acid-based Therapeutics Product and Service
-
Table BioMedica (Foundation Year, Company Profile and etc.)
-
Table BioMedica Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioMedica Nucleic Acid-based Therapeutics Product and Service
-
Table Imugene (Foundation Year, Company Profile and etc.)
-
Table Imugene Nucleic Acid-based Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Imugene Nucleic Acid-based Therapeutics Product and Service
-
